Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications

被引:48
作者
Duque, Alice [1 ]
Mediano, Mauro Felippe Felix [1 ,2 ]
De Lorenzo, Andrea [1 ]
Rodrigues Jr, Luiz Fernando [1 ,3 ]
机构
[1] Inst Nacl Cardiol, Educ & Res Dept, Rua Laranjeiras 374, BR-22240006 Rio De Janeiro, RJ, Brazil
[2] Evandro Chagas Natl Inst Infect Dis, Oswaldo Cruz Fdn, Lab Clin Res Chagas Dis, BR-21040360 Rio De Janeiro, RJ, Brazil
[3] Univ Fed Rio de Janeiro, Inst Biomed, Dept Physiol Sci, BR-22240006 Rio De Janeiro, RJ, Brazil
关键词
Cardiovascular autonomic neuropathy; Cardiac autonomic neuropathy; Diabetes mellitus; Heart rate variability; Sympathetic autonomic nervous system; Parasympathetic autonomic nervous system; HEART-RATE-VARIABILITY; RISK-FACTORS; CARDIAC DENERVATION; OXIDATIVE STRESS; NERVOUS-SYSTEM; QT INTERVAL; MORTALITY; DIAGNOSIS; DYSFUNCTION; IMPACT;
D O I
10.4239/wjd.v12.i6.855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular autonomic neuropathy (CAN) is a debilitating condition that mainly occurs in long-standing type 2 diabetes patients but can manifest earlier, even before diabetes is diagnosed. CAN is a microvascular complication that results from lesions of the sympathetic and parasympathetic nerve fibers, which innervate the heart and blood vessels and promote alterations in cardiovascular autonomic control. The entire mechanism is still not elucidated, but several aspects of the pathophysiology of CAN have already been described, such as the production of advanced glycation end products, reactive oxygen species, nuclear factor kappa B, and pro-inflammatory cytokines. This microvascular complication is an important risk factor for silent myocardial ischemia, chronic kidney disease, myocardial dysfunction, major cardiovascular events, cardiac arrhythmias, and sudden death. It has also been suggested that, compared to other traditional cardiovascular risk factors, CAN progression may have a greater impact on cardiovascular disease development. However, CAN might be subclinical for several years, and a late diagnosis increases the mortality risk. The duration of the transition period from the subclinical to clinical stage remains unknown, but the progression of CAN is associated with a poor prognosis. Several tests can be used for CAN diagnosis, such as heart rate variability (HRV), cardiovascular autonomic reflex tests, and myocardial scintigraphy. Currently, it has already been described that CAN could be detected even during the subclinical stage through a reduction in HRV, which is a non-invasive test with a lower operating cost. Therefore, considering that diabetes mellitus is a global epidemic and that diabetic neuropathy is the most common chronic complication of diabetes, the early identification and treatment of CAN could be a key point to mitigate the morbidity and mortality associated with this long-lasting condition.
引用
收藏
页数:14
相关论文
共 50 条
  • [11] Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management
    Williams, Scott
    Raheim, Siddig Abdel
    Khan, Muhammad Ilyas
    Rubab, Umme
    Kanagala, Prathap
    Zhao, Sizheng Steven
    Marshall, Anne
    Brown, Emily
    Alam, Uazman
    CLINICAL THERAPEUTICS, 2022, 44 (10) : 1394 - 1416
  • [12] Nocturnal ventricular arrhythmias are associated with the severity of cardiovascular autonomic neuropathy in type 2 diabetes
    Chen, Chuhui
    Wang, Weimin
    Zhou, Wen
    Jin, Jiewen
    Chen, Wei
    Zhu, Dalong
    Bi, Yan
    JOURNAL OF DIABETES, 2019, 11 (10) : 794 - 801
  • [13] Neuropad for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes
    Mendivil, Carlos O.
    Kattah, William
    Orduz, Arturo
    Tique, Claudia
    Cardenas, Jose L.
    Patino, Jorge E.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (01) : 93 - 98
  • [14] Baroreflex sensitivity with different lags and random forests for staging cardiovascular autonomic neuropathy in subjects with diabetes
    Petry, Daiana
    de Godoy Marques, Claudia Mirian
    Brum Marques, Jefferson Luiz
    COMPUTERS IN BIOLOGY AND MEDICINE, 2020, 127 (127)
  • [15] Cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus and coronary artery disease: Diagnosis and severity assessment
    Beshlieva, D. D.
    Kalashnikov, V. Yu.
    Smirnova, O. M.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (10) : 11 - 18
  • [16] Cardiac vagal tone as a novel screening tool to recognize asymptomatic cardiovascular autonomic neuropathy: Aspects of utility in type 1 diabetes
    Wegeberg, Anne-Marie
    Lunde, Elin D.
    Riahi, Sam
    Ejskjaer, Niels
    Drewes, Asbjorn M.
    Brock, Birgitte
    Pop-Busui, Rodica
    Brock, Christina
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 170
  • [17] Prevalence and Correlates of Cardiovascular Autonomic Neuropathy Among Patients with Diabetes in Uganda: A Hospital-Based Cross-sectional Study
    Migisha, Richard
    Agaba, David Collins
    Katamba, Godfrey
    Kwaga, Teddy
    Tumwesigye, Raymond
    Miranda, Silvia Lopez
    Muyingo, Anthony
    Siedner, Mark J.
    GLOBAL HEART, 2020, 15 (01)
  • [18] Cardiovascular autonomic neuropathy: A silent killer with long reach
    Ang, Lynn
    Dillon, Brendan
    Mizokami-Stout, Kara
    Pop-Busui, Rodica
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2020, 225
  • [19] Why Not to Use the Handgrip Test in the Assessment of Cardiovascular Autonomic Neuropathy Among Patients with Diabetes Mellitus?
    Korei, Anna E.
    Kempler, Miklos
    Istenes, Ildiko
    Vagi, Orsolya E.
    Putz, Zsuzsanna
    Horvath, Viktor J.
    Keresztes, Katalin
    Lengyel, Csaba
    Tabak, Adam Gy.
    Spallone, Vincenza
    Kempler, Peter
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (01) : 66 - 73
  • [20] Cardiovascular autonomic neuropathy and other complications in type 1 diabetes
    Pavy-Le Traon, Anne
    Fontaine, Sebastien
    Tap, Gerard
    Guidolin, Brigitte
    Senard, Jean-Michel
    Hanaire, Helene
    CLINICAL AUTONOMIC RESEARCH, 2010, 20 (03) : 153 - 160